Sime to invest RM97.7mil in US biotech company Verdezyne


President Barack Obama, standing right, and Malaysian Prime Minister Najib, standing left, applaud as Bill Radany, president & CEO of Verdezyne, right, and Tan Sri Dato' Seri Mohd Bakke Salleh, President & Group Chief Executive of Sime Darby Berhad, left, participate in the signing of major commercial agreements with American businesses at the Ritz-Carlton in Kuala Lumpur,

PETALING JAYA: Sime Darby Bhd is acquiring a substantial stake in United States-based industrial biotechnology company Verdezyne Inc to pursue strategic growth areas for its plantation business.

Sime Darby president and group chief executive officer Tan Sri Mohd Bakke Salleh said in a statement that “Sime Darby is taking strategically measured steps to build and nurture a sustainable portfolio of palm-related industrial biotechnology companies.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Sime Darby , Verdezyne , Barack Obama , Najib

   

Next In Business News

Surging dollar pressures Asian FX; S.Korean won leads losses
China set to keep lending benchmark LPRs unchanged in April
Gold rises as safe-haven appeal boosted by Israel's attack on Iran
MKH Oil Palm IPO oversubscribed by 8.4 times
Bank Negara adds four companies to Financial Consumer Alert list
Nissan cuts annual operating profit estimate by 14.5% on lower sales
Oil surges as reports of Israeli strike on Iran roil markets
Bitcoin slides below US$60,000 on reports Israel strikes Iran
Stocks sink, oil jumps after Israeli attack on Iran
Yinson Production successfully places US$500mil bond issue

Others Also Read